Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "machine-learning"

99 News Found

HCL Tech and Innovaccer collaborate to scale up digital health transformation
Digitisation | October 20, 2021

HCL Tech and Innovaccer collaborate to scale up digital health transformation

By combining Innovaccer's Data Activation Platform with HCL's robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance


Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation
Hospitals | September 29, 2021

Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation

Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age


Morpen Labs carves out diagnostics business to unlock value
Clinical Trials | September 29, 2021

Morpen Labs carves out diagnostics business to unlock value

The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India


US FDA grants Lantern Pharma additional Orphan Drug tag for LP-184
Biotech | August 31, 2021

US FDA grants Lantern Pharma additional Orphan Drug tag for LP-184

The drug is also intended for the treatment of glioblastoma multiforme


Xybion releases Pristima XD digital pathology
Digitisation | August 24, 2021

Xybion releases Pristima XD digital pathology

The module offers the first preclinical laboratory information system of its kind that is fully integrated into the digital pathology workflow and provides efficient pathological studies of whole slides


Delfi liquid biopsy shows promise for reducing lung cancer deaths
Biotech | August 23, 2021

Delfi liquid biopsy shows promise for reducing lung cancer deaths

When the Delfi technology was used as a pre-screen to determine if a low dose CT (LDCT), should be performed, the combined approach led to the detection of 90% of lung cancers, including 80% of stage I cancers


Global Healthcare Supply Chain Management market to reach US $ 3.6 billion by 2026
Supply Chain | August 11, 2021

Global Healthcare Supply Chain Management market to reach US $ 3.6 billion by 2026

A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report


QIAGEN and OncXerna Therapeutics sign licensing and master companion diagnostic agreements
Drug Approval | August 10, 2021

QIAGEN and OncXerna Therapeutics sign licensing and master companion diagnostic agreements

QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab


Pharma stalwarts demystify COVID-19 impact on industry
News | March 01, 2021

Pharma stalwarts demystify COVID-19 impact on industry

Reflecting on the learning during the pandemic, industry is aiming to push innovation in R&D and implement automation and digital technologies across various operational levels.